Home ›
Trademark Categories ›
Pharmaceuticals ›
2010 ›
IM ›
IMMUNOVATIVE THERAPIES
Trademark search for:
IMMUNOVATIVE THERAPIES
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2010-09-30 — Application filed
2010-10-04 — Application filed
2010-10-05 — Application filed
2011-01-10 — Assigned to examiner
2011-01-17 — Final disposition recorded
2011-01-17 — Final disposition recorded
2011-01-17 — Final disposition recorded
2011-07-12 — Teas amendment of use received
2011-07-12 — Office action issued
2011-07-12 — Teas/email correspondence entered
2011-07-12 — Correspondence received in law office
2011-07-13 — Use amendment filed
2011-07-13 — Amendment to use processing complete
2011-08-06 — Final disposition recorded
2011-08-06 — Amendment of alleged use disapproved
2011-08-06 — Disapproval - amendment to use e-mailed
2011-08-06 — Notification of disapproval - amendment to use e-mailed
2012-03-18 — Application abandoned
2012-03-19 — Application abandoned
2012-05-04 — Teas petition to revive received
2012-05-04 — Petition to revive-granted
2012-05-04 — Office action issued
2012-05-04 — Notice of revival - e-mailed
2012-05-17 — Assigned to lie
2012-05-24 — Correspondence received in law office
2012-05-24 — Teas/email correspondence entered
2012-06-12 — Final disposition recorded
2012-06-12 — Final disposition recorded
2012-06-12 — Final disposition recorded
2012-10-19 — Office action issued
2012-10-26 — Correspondence received in law office
2012-10-26 — Teas/email correspondence entered
2012-10-29 — Approved for pub - principal register
2012-11-02 — Law office publication review completed
2012-11-21 — Notification of notice of publication e-mailed
2012-12-11 — Published for opposition
2012-12-11 — Official gazette publication confirmation e-mailed
2013-02-05 — Noa e-mailed - sou required from applicant
2013-07-25 — Teas change of owner address received
2013-07-25 — Applicant/correspondence changes (non-responsive) entered
2013-07-29 — Sou teas extension received
2013-07-29 — Sou extension 1 filed
2013-07-29 — Sou extension 1 granted
2013-07-31 — Notice of approval of extension request e-mailed
2014-02-04 — Sou teas extension received
2014-02-04 — Sou extension 2 filed
2014-02-24 — Case assigned to intent to use paralegal
2014-02-25 — Sou extension 2 granted
2014-02-26 — Notice of approval of extension request e-mailed
2014-08-04 — Sou teas extension received
2014-08-04 — Sou extension 3 filed
2014-08-20 — Sou extension 3 granted
2014-08-21 — Notice of approval of extension request e-mailed
2014-12-04 — Teas petition to amend basis received
2014-12-15 — Petition to director - change basis - granted
2014-12-15 — Assigned to petition staff
2014-12-16 — Attorney review/decision on amendment required
2015-01-30 — Notice of allowance cancelled
2015-01-30 — 1(b) basis deleted; new basis requested
2015-02-18 — Notification of notice of publication e-mailed
2015-03-10 — Published for opposition
2015-03-10 — Official gazette publication confirmation e-mailed
2015-05-26 — Registered-principal register
2020-01-20 — Teas change of correspondence received
2020-05-26 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2021-12-03 — Cancelled sec. 8 (6-yr)
2021-12-03 — Final status recorded
Owner Information
Immunovative Therapies, Ltd.
Jerusalem IL
Immunovative Therapies, Ltd.
Jerusalem IL
Immunovative Therapies, Ltd.
Shoham IL
Correspondent
Z. PETER SAWICKI WESTMAN, CHAMPLIN & KOEHLER, P.A. 121 South Eighth Street, Suite 1100 MINNEAPOLIS, MN 55402 UNITED STATES
Filing Details
Filing Date:
2010-09-30
Status Date:
2021-12-03
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.